Deciphering the potential ability of DExD/H-box helicase 60 (DDX60) on the proliferation, diagnostic and prognostic biomarker in pancreatic cancer: a research based on silico, RNA-seq and molecular biology experiment
Abstract Background Pancreatic cancer is one of the most malignant abdominal tumors. DDX60 has been shown to be associated with a variety of tumor biological processes. However, DDX60 in pancreatic cancer has not been reported. Our study confirmed that DDX60 can serve as a novel biomarker for diagno...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | Hereditas |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s41065-024-00361-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832585671610466304 |
|---|---|
| author | Dongdong Zhang Enze Zhang Ying Cai Yixin sun Peiji Zeng Xiaohua Jiang Yifan Lian |
| author_facet | Dongdong Zhang Enze Zhang Ying Cai Yixin sun Peiji Zeng Xiaohua Jiang Yifan Lian |
| author_sort | Dongdong Zhang |
| collection | DOAJ |
| description | Abstract Background Pancreatic cancer is one of the most malignant abdominal tumors. DDX60 has been shown to be associated with a variety of tumor biological processes. However, DDX60 in pancreatic cancer has not been reported. Our study confirmed that DDX60 can serve as a novel biomarker for diagnosis and treatment of pancreatic cancer. Materials and methods We downloaded pancreatic cancer datasets from GEO and TCGA databases, respectively. To investigate the relationship between DDX60 expression and prognosis in pancreatic cancer. GSEA analysis was performed on DDX60. We performed RNA-seq to further explore the downstream biological targets of DDX60 and the signaling pathways that may be involved in pancreatic cancer. Finally, we tested it through molecular biology experiments. First, we constructed the plasmid and tested the plasmid effect by WB. Then MTT assay was performed to explore the effect of DDX60 knockout on the proliferation of pancreatic cancer cells. LDH assay was performed to explore the effect of DDX60 on the release of lactate dehydrogenase from tumor cells. The effect of DDX60 on cell proliferation was further explored by clonal formation experiment. Continue to explore clinical therapeutic drugs sensitive to DDX60 targets. Results By analyzing the GSE71729, GSE183795, GSE16515, GSE28735 and GSE62452 data sets, we found that DDX60 was highly expressed in pancreatic cancer. And is associated with poorer outcomes for pancreatic patients. The mRNA expression level of DDX60 was correlated with lymph node metastasis and grade in clinical pancreatic patients. Through the results of RNA-seq analysis, GO and KEGG analysis showed that DDX60 may be associated with cell cycle in pancreatic cancer. Through molecular biology experiments (MTT, LDH, and clonal formation experiment), we found that When DDX60 is knocked down in pancreatic cancer cells, the proliferation ability of tumor cells is significantly decreased. Several drugs targeting about DDX60 have been found, such as JW-7–52-1, this could provide direction for drug therapy against the DDX60 target. Conclusion In summary, DDX60 can be used as a novel biomarker related to the diagnosis and treatment of pancreatic cancer, participate in tumor proliferation, and is associated with poor prognosis in patients. |
| format | Article |
| id | doaj-art-d724a006d88848baabcc51868ef5cda0 |
| institution | Kabale University |
| issn | 1601-5223 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | BMC |
| record_format | Article |
| series | Hereditas |
| spelling | doaj-art-d724a006d88848baabcc51868ef5cda02025-01-26T12:36:41ZengBMCHereditas1601-52232025-01-01162112210.1186/s41065-024-00361-9Deciphering the potential ability of DExD/H-box helicase 60 (DDX60) on the proliferation, diagnostic and prognostic biomarker in pancreatic cancer: a research based on silico, RNA-seq and molecular biology experimentDongdong Zhang0Enze Zhang1Ying Cai2Yixin sun3Peiji Zeng4Xiaohua Jiang5Yifan Lian6Department of Gastroenterology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen UniversitySchool of Medicine, Xiamen UniversityDepartment of Gastroenterology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen UniversitySchool of Medicine, Xiamen UniversitySchool of Medicine, Xiamen UniversityDepartment of Orthopedics, Xiang’an Hospital of Xiamen University, School of Medicine, Xiamen UniversityDepartment of Gastroenterology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen UniversityAbstract Background Pancreatic cancer is one of the most malignant abdominal tumors. DDX60 has been shown to be associated with a variety of tumor biological processes. However, DDX60 in pancreatic cancer has not been reported. Our study confirmed that DDX60 can serve as a novel biomarker for diagnosis and treatment of pancreatic cancer. Materials and methods We downloaded pancreatic cancer datasets from GEO and TCGA databases, respectively. To investigate the relationship between DDX60 expression and prognosis in pancreatic cancer. GSEA analysis was performed on DDX60. We performed RNA-seq to further explore the downstream biological targets of DDX60 and the signaling pathways that may be involved in pancreatic cancer. Finally, we tested it through molecular biology experiments. First, we constructed the plasmid and tested the plasmid effect by WB. Then MTT assay was performed to explore the effect of DDX60 knockout on the proliferation of pancreatic cancer cells. LDH assay was performed to explore the effect of DDX60 on the release of lactate dehydrogenase from tumor cells. The effect of DDX60 on cell proliferation was further explored by clonal formation experiment. Continue to explore clinical therapeutic drugs sensitive to DDX60 targets. Results By analyzing the GSE71729, GSE183795, GSE16515, GSE28735 and GSE62452 data sets, we found that DDX60 was highly expressed in pancreatic cancer. And is associated with poorer outcomes for pancreatic patients. The mRNA expression level of DDX60 was correlated with lymph node metastasis and grade in clinical pancreatic patients. Through the results of RNA-seq analysis, GO and KEGG analysis showed that DDX60 may be associated with cell cycle in pancreatic cancer. Through molecular biology experiments (MTT, LDH, and clonal formation experiment), we found that When DDX60 is knocked down in pancreatic cancer cells, the proliferation ability of tumor cells is significantly decreased. Several drugs targeting about DDX60 have been found, such as JW-7–52-1, this could provide direction for drug therapy against the DDX60 target. Conclusion In summary, DDX60 can be used as a novel biomarker related to the diagnosis and treatment of pancreatic cancer, participate in tumor proliferation, and is associated with poor prognosis in patients.https://doi.org/10.1186/s41065-024-00361-9DDX60RNA-seqPancreatic cancer; prognosticTCGAGEOBiomarker |
| spellingShingle | Dongdong Zhang Enze Zhang Ying Cai Yixin sun Peiji Zeng Xiaohua Jiang Yifan Lian Deciphering the potential ability of DExD/H-box helicase 60 (DDX60) on the proliferation, diagnostic and prognostic biomarker in pancreatic cancer: a research based on silico, RNA-seq and molecular biology experiment Hereditas DDX60 RNA-seq Pancreatic cancer; prognostic TCGA GEO Biomarker |
| title | Deciphering the potential ability of DExD/H-box helicase 60 (DDX60) on the proliferation, diagnostic and prognostic biomarker in pancreatic cancer: a research based on silico, RNA-seq and molecular biology experiment |
| title_full | Deciphering the potential ability of DExD/H-box helicase 60 (DDX60) on the proliferation, diagnostic and prognostic biomarker in pancreatic cancer: a research based on silico, RNA-seq and molecular biology experiment |
| title_fullStr | Deciphering the potential ability of DExD/H-box helicase 60 (DDX60) on the proliferation, diagnostic and prognostic biomarker in pancreatic cancer: a research based on silico, RNA-seq and molecular biology experiment |
| title_full_unstemmed | Deciphering the potential ability of DExD/H-box helicase 60 (DDX60) on the proliferation, diagnostic and prognostic biomarker in pancreatic cancer: a research based on silico, RNA-seq and molecular biology experiment |
| title_short | Deciphering the potential ability of DExD/H-box helicase 60 (DDX60) on the proliferation, diagnostic and prognostic biomarker in pancreatic cancer: a research based on silico, RNA-seq and molecular biology experiment |
| title_sort | deciphering the potential ability of dexd h box helicase 60 ddx60 on the proliferation diagnostic and prognostic biomarker in pancreatic cancer a research based on silico rna seq and molecular biology experiment |
| topic | DDX60 RNA-seq Pancreatic cancer; prognostic TCGA GEO Biomarker |
| url | https://doi.org/10.1186/s41065-024-00361-9 |
| work_keys_str_mv | AT dongdongzhang decipheringthepotentialabilityofdexdhboxhelicase60ddx60ontheproliferationdiagnosticandprognosticbiomarkerinpancreaticcanceraresearchbasedonsilicornaseqandmolecularbiologyexperiment AT enzezhang decipheringthepotentialabilityofdexdhboxhelicase60ddx60ontheproliferationdiagnosticandprognosticbiomarkerinpancreaticcanceraresearchbasedonsilicornaseqandmolecularbiologyexperiment AT yingcai decipheringthepotentialabilityofdexdhboxhelicase60ddx60ontheproliferationdiagnosticandprognosticbiomarkerinpancreaticcanceraresearchbasedonsilicornaseqandmolecularbiologyexperiment AT yixinsun decipheringthepotentialabilityofdexdhboxhelicase60ddx60ontheproliferationdiagnosticandprognosticbiomarkerinpancreaticcanceraresearchbasedonsilicornaseqandmolecularbiologyexperiment AT peijizeng decipheringthepotentialabilityofdexdhboxhelicase60ddx60ontheproliferationdiagnosticandprognosticbiomarkerinpancreaticcanceraresearchbasedonsilicornaseqandmolecularbiologyexperiment AT xiaohuajiang decipheringthepotentialabilityofdexdhboxhelicase60ddx60ontheproliferationdiagnosticandprognosticbiomarkerinpancreaticcanceraresearchbasedonsilicornaseqandmolecularbiologyexperiment AT yifanlian decipheringthepotentialabilityofdexdhboxhelicase60ddx60ontheproliferationdiagnosticandprognosticbiomarkerinpancreaticcanceraresearchbasedonsilicornaseqandmolecularbiologyexperiment |